These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 17493313)
1. Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation. Clegg AJ; Scott DA; Loveman E; Colquitt J; Royle P; Bryant J Int J Technol Assess Health Care; 2007; 23(2):261-8. PubMed ID: 17493313 [TBL] [Abstract][Full Text] [Related]
2. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098 [TBL] [Abstract][Full Text] [Related]
3. Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation. Clegg AJ; Scott DA; Loveman E; Colquitt JL; Royle P; Bryant J Eur Heart J; 2006 Dec; 27(24):2929-38. PubMed ID: 16603577 [TBL] [Abstract][Full Text] [Related]
4. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment. Health Quality Ontario Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901 [TBL] [Abstract][Full Text] [Related]
6. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure. McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762 [TBL] [Abstract][Full Text] [Related]
7. Economic Evaluation of Left Ventricular Assist Devices for Patients With End Stage Heart Failure Who Are Ineligible for Cardiac Transplantation. Chew DS; Manns B; Miller RJH; Sharma N; Exner DV Can J Cardiol; 2017 Oct; 33(10):1283-1291. PubMed ID: 28941608 [TBL] [Abstract][Full Text] [Related]
8. Improving outcomes with long-term "destination" therapy using left ventricular assist devices. Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385 [TBL] [Abstract][Full Text] [Related]
9. Ethical challenges with the left ventricular assist device as a destination therapy. Rizzieri AG; Verheijde JL; Rady MY; McGregor JL Philos Ethics Humanit Med; 2008 Aug; 3():20. PubMed ID: 18694496 [TBL] [Abstract][Full Text] [Related]
10. Modeling payback from research into the efficacy of left-ventricular assist devices as destination therapy. Girling AJ; Freeman G; Gordon JP; Poole-Wilson P; Scott DA; Lilford RJ Int J Technol Assess Health Care; 2007; 23(2):269-77. PubMed ID: 17493314 [TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure. Baras Shreibati J; Goldhaber-Fiebert JD; Banerjee D; Owens DK; Hlatky MA JACC Heart Fail; 2017 Feb; 5(2):110-119. PubMed ID: 28017351 [TBL] [Abstract][Full Text] [Related]
12. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure. Long EF; Swain GW; Mangi AA Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450 [TBL] [Abstract][Full Text] [Related]
13. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018 [TBL] [Abstract][Full Text] [Related]
14. Left ventricular assist devices as destination therapy: a new look at survival. Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819 [TBL] [Abstract][Full Text] [Related]
15. The cost-utility of left ventricular assist devices for end-stage heart failure patients ineligible for cardiac transplantation: a systematic review and critical appraisal of economic evaluations. Neyt M; Van den Bruel A; Smit Y; De Jonge N; Vlayen J Ann Cardiothorac Surg; 2014 Sep; 3(5):439-49. PubMed ID: 25452904 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of continuous-flow left ventricular assist devices. Neyt M; Van den Bruel A; Smit Y; De Jonge N; Erasmus M; Van Dijk D; Vlayen J Int J Technol Assess Health Care; 2013 Jul; 29(3):254-60. PubMed ID: 23763844 [TBL] [Abstract][Full Text] [Related]